Glenmark and Mitelos Announce Partnership Agreement for WASHDENT® in the British market

Watford (UK) – Cerdanyola, Barcelona (Spain); May 3rd, 2018: Under this agreement, Glenmark receives exclusive rights to the United Kingdom for this product addressed to oral care.

Glenmark Pharmaceuticals, a global pharmaceutical company and Mitelos, a business to business innovation-driven company, announced that they have entered into a distribution and commercial supply agreement that grants the former the exclusive rights to market WASHDENT® in the United Kingdom.

In turn, Mitelos expands the list of countries in which the product is to be placed on the market imminently, including France, Belgium, Malaysia, Singapore, etc.

According to the “2014-Food and You Survey” commissioned by the public Food Standards Agency, three-quarters of respondents (75%) reported that they had eaten out or bought food to take away in the previous seven days. WASHDENT® is a new concept within the oral care arena that promotes dental health in a complementary way to the recommended hygiene habits such as brushing and flossing.

Mitelos is actively looking for partners willing to distribute WASHDENT® in their countries. Please, contact us if you want to learn more about this product and its line extension WASHDENT JUNIOR® , or visite the website www.washdent.eu.